The healthcare technology (HealthTech) sector has transitioned from a phase of greenfield venture formation to one characterized by rapid platform consolidation. Driven by post-pandemic market corrections, rising operational costs, and regulatory evolution, strategic corporate buyers and private equity sponsors are executing aggressive platform strategies and buy-and-build consolidation programs.